Professor Ronald F van Vollenhoven is chief of the Unit for Clinical Therapy Research, Inflammatory Diseases (ClinTRID) at the Karolinska Institute, and of the Clinical Trials Unit Rheumatology at the Karolinska University Hospital.
EDUCATION AND TRAINING:
He received his MD and PhD degrees from the University of Leiden in The Netherlands. After graduating in 1984, he pursued immunology research at Cornell Medical College in New York followed by residency (specialty training) in internal medicine at the State University of New York at Stony Brook, and a fellowship in rheumatology at Stanford University in Palo Alto. After this he received American Board of Internal Medicine certification in both internal medicine and rheumatology.
From 1993 to 1998 Professor van Vollenhoven held a faculty appointment as Assistant Professor of Medicine in the Division of Immunology and Rheumatology at Stanford University, and from 1995 he was the Medical Services Chief and Fellowship Director in that division.
In 1998 Professor van Vollenhoven moved to Stockholm, Sweden, where he worked as a Senior Physician and Chief of the Clinical Trials Unit in the Department of Rheumatology at the Karolinska University Hospital and Associate Professor of Rheumatology, and in 2010 he was appointed in his current position at the Karolinska Institute.
AWARDS / MEMBERSHIPS:
In 2004, Professor van Vollenhoven was awarded the Scandinavian Research Foundation Prize for excellence in clinical research in rheumatology. He is member of several editorial boards and the EULAR scientific programme committee, chair of the Swedish health economics working group HeraS, and co-founder of the IRBIS registry for biologics in SLE and of the NORD-STAR collaboration for Nordic trials in the rheumatic diseases.
Professor van Vollenhoven's research interests focus around the development and systematic evaluation of biological and immunomodulatory treatments for the rheumatic diseases. With his co-workers, he has established the Stockholm registry for biological therapies (the STURE database) for this purpose, which has supported research projects relating to clinical efficacy, pharmacology, outcomes and pharmacoeconomics. He has been principal investigator in many clinical trials of novel therapies in rheumatic diseases and has contributed to a number of important investigator-initiated trials including the recently published SWEFOT trial. He has published over 150 original papers, book chapters and reviews, and is editor of the textbook Targeted Treatment of the Rheumatic Diseases.
In the role of Faculty Member, Ronald van Vollenhoven contributes recommendations and reviews to the Immune & Inflammatory Rheumatic Diseases (incl. Arthritis) Section in the Rheumatology & Clinical Immunology Faculty, writing brief accessible comments to summarize the value of the articles and adding rating score.
The Faculty comprises Heads of Faculty, Heads of Section, Faculty Members and Associate Faculty Members, as well as an International Advisory Board.
Read more about F1000Prime »